Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the completion of the sale, the director directly owned 1,574,498 shares of the company’s stock, valued at approximately $261,650,077.64. This represents a 8.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Manuel Alba also recently made the following trade(s):
- On Monday, December 1st, Manuel Alba sold 33,000 shares of Astera Labs stock. The shares were sold at an average price of $166.18, for a total transaction of $5,483,940.00.
Astera Labs Price Performance
NASDAQ:ALAB traded up $9.56 during trading hours on Wednesday, reaching $152.50. 7,756,719 shares of the stock were exchanged, compared to its average volume of 6,575,237. The stock has a market cap of $25.76 billion, a PE ratio of 172.22, a PEG ratio of 2.66 and a beta of 1.51. The firm has a 50 day moving average of $172.77 and a 200 day moving average of $150.19. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90.
Hedge Funds Weigh In On Astera Labs
Analysts Set New Price Targets
Several equities research analysts recently issued reports on the company. Susquehanna raised their target price on shares of Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a research note on Thursday, August 7th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a research note on Tuesday, September 2nd. Evercore ISI increased their price target on shares of Astera Labs from $104.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, August 6th. Northland Capmk upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Monday, November 17th. Finally, JPMorgan Chase & Co. upped their price target on Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $187.06.
Get Our Latest Stock Report on ALAB
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories
- Five stocks we like better than Astera Labs
- Upcoming IPO Stock Lockup Period, Explained
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- Insider Trading – What You Need to Know
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- How to Buy Cheap Stocks Step by Step
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
